Lexicon Pharmaceuticals, Inc. (LXRX)
1.59
-0.05
(-3.05%)
USD |
NASDAQ |
Apr 02, 16:00
1.58
-0.01
(-0.63%)
After-Hours: 17:20
Lexicon Pharmaceuticals Research and Development Expense (TTM) : 60.50M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viemed Healthcare, Inc. | 3.017M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Novavax, Inc. | 338.72M |
| Kura Oncology, Inc. | 251.07M |
| Liquidia Corp. | 38.35M |